Atlas Trials

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Clinical trial NCT04576949 · COMPLETED

Trial details

NCT number
NCT04576949
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2020-10-13
Primary completion
2021-12-23
Enrollment
810

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.